SHERIDAN, WYOMING – October 7, 2024 – Zana, an innovative health tech company specializing in AI-powered voice analysis, is set to make a significant impact at the upcoming MEDICA HEALTH IT FORUM 2024 in Düsseldorf. The company will be presenting its groundbreaking technology, which utilizes artificial intelligence to analyze vocal biomarkers for early detection and monitoring of various health conditions, with a particular focus on Chronic Obstructive Pulmonary Disease (COPD).
Zana's proprietary AI models identify subtle changes in voice patterns that may indicate deterioration in respiratory health, allowing for proactive intervention and personalized care. This technology has the potential to revolutionize COPD management by enabling early detection of exacerbations, predicting potential health decline, and supporting clinical decision-making with objective assessments of illness progression.
"This solution also supports clinical decisions and objective assessment of the course of illness and is a very innovative method," states the company. By identifying acute deterioration beyond daily fluctuations, Zana empowers healthcare professionals to make more informed decisions and provide timely interventions, ultimately improving patient outcomes and quality of life.
The MEDICA HEALTH IT FORUM, a leading platform for digital healthcare innovation, provides the perfect stage for Zana to showcase its technology to a global audience of healthcare professionals, industry experts, and investors. Zana's presence at the forum underscores the growing importance of AI in shaping the future of healthcare and highlights the company's commitment to developing responsible and ethical AI solutions.
Dr. Julia Hoxha, co-founder and managing director of Zana, will be a key speaker at the forum, participating in a panel discussion on "AI and the Future of Healthcare." Dr. Hoxha, who also heads the Health Working Group at the German AI Association, will address the challenges and opportunities associated with integrating AI into healthcare systems, emphasizing the importance of regulatory frameworks like the EU's "AI Act" in ensuring patient safety and data privacy. "If things go badly, the costs for these applications will increase," she warns. "But you can plan well and design intelligently, then these costs can be avoided."
Zana's participation in the MEDICA HEALTH IT FORUM 2024 marks a significant step forward in the company's mission to transform healthcare through the power of AI. By actively engaging in the dialogue surrounding the ethical and responsible development of AI in healthcare, Zana is paving the way for a future where technology empowers both patients and healthcare providers.